Regarding the prognostic factors in patients with ALK-positive non-small cell lung cancer treated with crizotinib

Pulmonology. 2024 Feb 23:S2531-0437(24)00019-9. doi: 10.1016/j.pulmoe.2024.02.007. Online ahead of print.

Authors

Limei Hu¹, Youjun Xie¹, Hongying Zhao²

Affiliations

¹ Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi, China.
² Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi, China. Electronic address: wanzhy196344@163.com.

PMID: 38402122
DOI: 10.1016/j.pulmoe.2024.02.007

No abstract available

Publication types

Letter